Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials

2020219 citationsJournal Articlegold Open Access

Authors

Abstract

The efficacies associated with PD-1/PD-L1 monotherapy vary significantly across cancer types and PD-L1 expression. This comprehensive summary of clinical benefit from immunotherapy in cancer patients provides an important guide for clinicians.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Pancreatic and Hepatic Oncology Research Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Therapeutic Advances in Medical Oncology

Volume 12, pp. 1758835920937612-1758835920937612

DOI: 10.1177/1758835920937612

Field-Weighted Citation Impact: 7.03